Polaris Wealth Advisory Group, LLC Biomarin Pharmaceutical Inc Transaction History

Polaris Wealth Advisory Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$72.61 - $90.2 $3.25 Million - $4.03 Million	-44,728 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$71.87 - $131.03 $3.21 Million - $5.86 Million	44,728 New	44,728 $3.44 Million
Q4 2018 Jan 17, 2019	SELL	$80.14 - $106.07 $4,808 - $6,364	-60 Closed	0 $0
Q3 2018 Oct 19, 2018	BUY	$93.92 - $105.72 $5,635 - $6,343	60 New	60 $6,000
Q2 2018 Jul 09, 2018	SELL	$76.01 - $99.03 $4,560 - $5,941	-60 Closed	0 $0
Q1 2018 Apr 09, 2018	BUY	$77.67 - $92.63 $4,660 - $5,557	60 New	60 $5,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Polaris Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Polaris Wealth Advisory Group, LLC with notifications on news.